Insight Center: Events & Webinars

Financing Your Life Sciences Company

Speakers: Merrill M. Kraines and David M. Santangelo

5:30 PM - 7:30 PM (EDT)
Financing Your Life Sciences Company

Beer, wine and hors d'oeuvres will be served.

From private placements to public offerings to strategic alliances, life sciences companies have myriad possibilities for funding future growth. But which course is the best course, and what should companies consider when pursuing a particular deal? This discussion, moderated by Pepper attorneys Merrill M. Kraines and David M. Santangelo, along with EisnerAmper partner John Pennett, will examine the latest trends in life sciences financing and present the perspectives of both investors and life sciences companies. Our panelists, Eric Cheng, Senior Managing Director, Head of Healthcare Investment Banking and Ritesh Veera, Managing Director, Investment Banking at Maxim, and Alan Roemer, Senior Vice President, Corporate Development at Roivant Sciences will discuss:

  • State of the life sciences capital markets
  • Types and stages of companies currently attractive to investors
  • Valuations and size of transactions
  • Accessing public markets
  • Private placements, IPOs and uplistings
  • Financing alternatives
  • Company perspectives on accessing capital

Pepper Hamilton LLP
The New York Times Building
620 Eighth Avenue - 37th Floor
New York, NY 10018-1405


There is no cost to attend.

Contact Kim MacAlister at macalisterk@pepperlaw.com or 215.981.4249 with any questions.

Data protection laws have changed, so we have revised our Privacy Policy.